Profil
Jean-Francois H.
Geschwind is associated with two companies, Sentient Technology, Inc. and Cage Pharma, Inc. He is the founder of both companies.
Sentient Technology, Inc. was founded in 2008, and no title is mentioned for him.
Cage Pharma, Inc. is also founded in 2008, and he holds the title of Chief Executive Officer & Director, which he still holds.
Aktive Positionen von Jean-Francois H. Geschwind
Unternehmen | Position | Beginn |
---|---|---|
Cage Pharma, Inc.
Cage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cage Pharma, Inc. operates as a developmental stage bio-pharmaceutical company. It focuses on developing anti-cancer drugs. The company was founded on October 24, 2008 by Jean–Francois H. Geschwind and is headquartered in Potomac, MD. | Gründer | 24.10.2008 |
Ehemalige bekannte Positionen von Jean-Francois H. Geschwind
Unternehmen | Position | Ende |
---|---|---|
Sentient Technology, Inc.
Sentient Technology, Inc. Medical SpecialtiesHealth Technology Sentient Bioscience, Inc. develops technology for embolization therapy and site-specific drug delivery to treat cancer and other diseases. The company was founded by Jean Francois H. Geschwind, Edith Mathiowitz and Timothy Murphy on August 14, 2008 and is headquartered in Providence, RI. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Cage Pharma, Inc.
Cage Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cage Pharma, Inc. operates as a developmental stage bio-pharmaceutical company. It focuses on developing anti-cancer drugs. The company was founded on October 24, 2008 by Jean–Francois H. Geschwind and is headquartered in Potomac, MD. | Health Technology |
Sentient Technology, Inc.
Sentient Technology, Inc. Medical SpecialtiesHealth Technology Sentient Bioscience, Inc. develops technology for embolization therapy and site-specific drug delivery to treat cancer and other diseases. The company was founded by Jean Francois H. Geschwind, Edith Mathiowitz and Timothy Murphy on August 14, 2008 and is headquartered in Providence, RI. | Health Technology |